Double-blind, placebo-controlled, randomised N=1 study to determine the effect of concomitant treatment with dehydroepiandrosterone on mood in women who experience mood disturbances during oral contraception-use.

Trial Profile

Double-blind, placebo-controlled, randomised N=1 study to determine the effect of concomitant treatment with dehydroepiandrosterone on mood in women who experience mood disturbances during oral contraception-use.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Jun 2011

At a glance

  • Drugs Prasterone (Primary)
  • Indications Mood disorders
  • Focus Therapeutic Use
  • Acronyms ARC-MOOD
  • Most Recent Events

    • 17 Jul 2010 Status changed from planning to active, no longer recruiting.
    • 19 May 2010 Interim results reporting patient compliance presented at the 11th Congress of the European Society of Contraception.
    • 14 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top